Institution identification

PURI

https://redirect.ema.europa.eu/resource/8998

Institution ID

8998

Institution full name and acronym

Real World & Late Phase Research (RWLPR), Quintiles

Institution countries

France

Type of institution

Other

Institution website

ENCePP partner

Yes
Institution description
Determining the right approach to achieve research objectives requires expertise and experience in real-world and late phase research. Quintiles,a leader in interventional IIIb/IV studies and observational research,is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. Whether monitoring safety and evaluating benefit risk or demonstrating effectiveness and gaining market access or proving efficacy in new indications and new formulations,Quintiles offers you a comprehensive approach to evidence development.Patient registries – Experience in conducting product,disease and pregnancy registries.Quality of life and patient-reported outcomes – Evidence to support benefits/claims in product labeling.Safety outcomes/REMS – Safety and risk monitoring over longer periods of time,also monitoring off-label use.Comparative effectiveness – Studies to provide evidence of effectiveness in different populations.Health outcomes/health economics –
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact